Role of Bibersteinia trehalosi, respiratory syncytial virus, and parainfluenza-3 virus in bighorn sheep pneumonia

被引:27
作者
Dassanayake, Rohana P. [1 ]
Shanthalingam, Sudarvili [1 ]
Subramaniam, Renuka [1 ]
Herndon, Caroline N. [1 ]
Bavananthasivam, Jegarubee [1 ]
Haldorson, Gary J. [1 ,2 ]
Foreyt, William J. [1 ]
Evermann, James F. [1 ,2 ]
Herrmann-Hoesing, Lynn M. [3 ]
Knowles, Donald P. [1 ,3 ]
Srikumaran, Subramaniam [1 ]
机构
[1] Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA
[2] Washington State Univ, Washington Anim Dis Diagnost Lab, Pullman, WA 99164 USA
[3] Washington State Univ, USDA ARS, Anim Dis Res Unit, Pullman, WA 99164 USA
关键词
Bighorn sheep; Pneumonia; Bibersteinia trehalosi; Mannheimia haemolytica; Respiratory syncytial virus; Parainfluenza-3; virus; OVIS-CANADENSIS-CANADENSIS; PASTEURELLA-HAEMOLYTICA; MANNHEIMIA-HAEMOLYTICA; MYCOPLASMA-OVIPNEUMONIAE; DOMESTIC SHEEP; BOVINE HERPESVIRUS-1; DISEASE; INFECTION;
D O I
10.1016/j.vetmic.2012.08.029
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Pneumonic bighorn sheep (BHS) have been found to be culture- and/or sero-positive for Bibersteinia trehalosi, respiratory syncytial virus (RSV), and parainfluenza-3 virus (PI-3). The objective of this study was to determine whether these pathogens can cause fatal pneumonia in BHS. In the first study, two groups of four BHS each were intra-tracheally administered with leukotoxin-positive (Group I) or leukotoxin-negative (Group II) B. trehalosi. All four animals in Group I developed severe pneumonia, and two of them died within 3 days. The other two animals showed severe pneumonic lesions on euthanasia and necropsy. Animals in Group II neither died nor showed gross pneumonic lesions on necropsy, suggesting that leukotoxin-positive, but not leukotoxin-negative, B. trehalosi can cause fatal pneumonia in BHS. In the second study, two other groups of four BHS (Groups III and IV) were intra-nasally administered with a mixture of RSV and PI-3. Four days later, RSV/PI-3-inoculated Group IV and another group of four BHS (Group V, positive control) were intra-nasally administered with Mannheimia haemolytica, the pathogen that consistently causes fatal pneumonia in BHS. All four animals in group III developed pneumonia, but did not die during the study period. However all four animals in Group IV, and three animals in Group V developed severe pneumonia and died within two days of M. haemolytica inoculation. The fourth animal in Group V showed severe pneumonic lesions on euthanasia and necropsy. These findings suggest that RSV/PI-3 can cause non-fatal pneumonia, but are not necessary predisposing agents for M. haemolytica-caused pneumonia of BHS. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:166 / 172
页数:7
相关论文
共 50 条
  • [21] Treatment of respiratory failure due to respiratory syncytial virus pneumonia with natural surfactant
    Vos, GD
    Rijtema, MN
    Blanco, CE
    PEDIATRIC PULMONOLOGY, 1996, 22 (06) : 412 - 415
  • [22] Homologous recombination as a mechanism of genetic changes in bovine parainfluenza-3 virus
    Alatorre-Garcia, Thalia A.
    Fonseca-Coronado, Salvador
    Gonzalez-Candelas, Fernando
    VETERINARY MICROBIOLOGY, 2021, 261
  • [23] A respiratory syncytial virus (RSV) vaccine based on parainfluenza virus 5 (PIV5)
    Phan, Shannon I.
    Chen, Zhenhai
    Xu, Pei
    Li, Zhuo
    Gao, Xiudan
    Foster, Stephanie L.
    Teng, Michael N.
    Tripp, Ralph A.
    Sakamoto, Kaori
    He, Biao
    VACCINE, 2014, 32 (25) : 3050 - 3057
  • [24] FIELD EVALUATION OF A RESPIRATORY SYNCYTIAL VIRUS VACCINE AND A TRIVALENT PARAINFLUENZA VIRUS VACCINE IN A PEDIATRIC POPULATION
    CHIN, J
    MAGOFFIN, RL
    SHEARER, LA
    SCHIEBLE, JH
    LENNETTE, EH
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1969, 89 (04) : 449 - +
  • [25] Severe respiratory syncytial virus pneumonia associated with primary Epstein-Barr virus infection
    Abughali, N
    Khiyami, A
    Birnkrant, DJ
    Kumar, ML
    PEDIATRIC PULMONOLOGY, 2002, 33 (05) : 395 - 398
  • [26] Titanium dioxide nanoparticles exacerbate pneumonia in respiratory syncytial virus (RSV)-infected mice
    Hashiguchi, Seiko
    Yoshida, Hiroki
    Akashi, Toshi
    Komemoto, Keiji
    Ueda, Tomoyuki
    Ikarashi, Yoshiaki
    Miyauchi, Aki
    Konno, Katsuhiko
    Yamanaka, Sayoko
    Hirose, Akihiko
    Kurokawa, Masahiko
    Watanabe, Wataru
    ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY, 2015, 39 (02) : 879 - 886
  • [27] Dual Inhibition of Human Parainfluenza Type 3 and Respiratory Syncytial Virus Infectivity with a Single Agent
    Outlaw, Victor K.
    Bottom-Tanzer, Samantha
    Kreitler, Dale F.
    Gellman, Samuel H.
    Porotto, Matteo
    Moscona, Anne
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2019, 141 (32) : 12648 - 12656
  • [28] Epidemiology and Characteristics of Respiratory Syncytial Virus Pneumonia in Critically Ill Adults
    Kim, Taeeun
    Huh, Jin Won
    Hong, Sang-Bum
    Jung, Jiwon
    Kim, Min Jae
    Chong, Yong Pil
    Sung, Heungsup
    Doh, Kyung Hyun
    Kim, Sung-Han
    Lee, Sang-Oh
    Kim, Yang Soo
    Lim, Chae-Man
    Koh, Younsuck
    Choi, Sang-Ho
    OPEN FORUM INFECTIOUS DISEASES, 2023, 10 (04):
  • [29] Immunogenicity of a modified-live virus vaccine against bovine viral diarrhea virus types 1 and 2, infectious bovine rhinotracheitis virus, bovine parainfluenza-3 virus, and bovine respiratory syncytial virus when administered intranasally in young calves
    Xue, Wenzhi
    Ellis, John
    Mattick, Debra
    Smith, Linda
    Brady, Ryan
    Trigo, Emilio
    VACCINE, 2010, 28 (22) : 3784 - 3792
  • [30] Respiratory syncytial virus (RSV) pneumonia in a southern muriqui (Brachyteles arachnoides)
    Santos, S. V.
    Strefezzi, R. F.
    Pissinatti, A.
    Takakura, C. F. H.
    Kanamura, C.
    Duarte, M. I. S.
    Catao-Dias, J. L.
    JOURNAL OF MEDICAL PRIMATOLOGY, 2012, 41 (06) : 403 - 406